 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other Feb 19 Calls Today's Calls |
| Call Details | |||
| NeuroMetrix Inc. Earnings Conference Call (Q4 2012) Scheduled to start Tue, Feb 19, 2013, 8:00 am Eastern -- this event is ongoing now--
| |||
| About NeuroMetrix Inc (NasdaqCM:NURO) | |||
| NeuroMetrix, Inc., a medical device company, engages in the development and marketing of products that aid physicians in the assessment and treatment of diseases and injuries of peripheral nerves, and provide regional anesthesia and pain control. The company provides ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures; NC-stat System, a point-of-service neurodiagnostic solution for the performance of nerve conduction studies; and consumables and accessories for use with its neurodiagnostic equipment. The company is also developing the ASCEND platform, a proprietary neuro-electrical guidance system; NM101, for use in chronic spinal cord injury; and Andara Oscillating Frequency Stimulation device that is designed as a single use implant to enhance neurological recovery in patients with devastating loss of movement and sensation from acute spinal cord injuries. The company offers NC-stat System primarily to primary care and internal medicine physicians; and ADVANCE NCS/EMG System to neurologists, physical medicine and rehabilitation physicians, neurosurgeons, orthopedic and hand surgeons, and pain medicine physicians. It sells its products directly to physician offices, clinics, and hospitals in the United States and internationally. The company has a strategic alliance with Cyberkinetics. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts. | |||
More Info: | |||
